Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2584182 | 0.90 | TK1 (0.55) | TK1 | |
| SCHEMBL9321738 | 0.87 | TK1 (0.53) | TK1 | |
| SCHEMBL9012069 | 0.87 | TK1 (0.53) | TK1 | |
| SCHEMBL9321653 | 0.87 | TK1 (0.53) | TK1 | |
| SCHEMBL11202967 | 0.85 | TK1 (0.53) | TK1TYMS | |
| SCHEMBL11202965 | 0.85 | TK1 (0.53) | TK1TYMS | |
| SCHEMBL5583976 | 0.80 | TK1 (0.61) | TK1 | |
| SCHEMBL2056547 | 0.80 | TK1 (0.61) | TK1 | |
| SCHEMBL2056551 | 0.80 | TK1 (0.61) | TK1 | |
| SCHEMBL1857100 | 0.80 | TYMS (0.53) | TK1TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0902788-B1 | NUCLEOSIDE DERIVATIVES, AND THEIR USE IN OLIGONUCLEOTIDE SYNTHESIS | CIS BIO INT (FR) | 2003-03-19 | — | — | EP | disclosed |
| US-6187914-B1 | SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDES USING ELECTROCHEMICALLY LABILE PROTECTING GROUPS WHICH CAN BE REMOVED BY CREATING POTENTIAL DIFFERENCE BETWEEN WORKING ELECTRODE AND COUNTERELECTRODE | CIS BIO INTERNATIONAL (FR) | 2001-02-13 | — | — | US | disclosed |
| EP-0902788-A1 | NUCLEOSIDE DERIVATIVES, AND THEIR USE IN OLIGONUCLEOTIDE SYNTHESIS | CIS BIO INTERNATIONAL (FR) | 1999-03-24 | — | — | EP | disclosed |
| WO-1997042207-A1 | NUCLEOSIDE DERIVATIVES, AND THEIR USE IN OLIGONUCLEOTIDE SYNTHESIS | CIS BIO INTERNATIONAL (FR) | 1997-11-13 | — | — | WO | disclosed |